Pulmonary Disease, Chronic Obstructive: all 4,252 studies

Page 42 of 43. Open to participants first (707), then studies with results posted, then the rest; newest registration first within each.

• Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
• Spiriva® Assessment of FEV1 (SAFE)CompletedNCT00277264Phase 3
• Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
• Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
• A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
• Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00274508Phase 3
• Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274092Phase 3
• SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
• Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
• Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
• Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
• Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)CompletedNCT00274027Phase 3
• Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory DisordersCompletedNCT00274014Phase 3
• Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)CompletedNCT00269126Phase 3
• Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung ClinicsCompletedNCT00268866
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00268216Phase 3
• Airway Inflammation In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00268177Phase 3
• Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.CompletedNCT00267917Phase 4
• Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPDTerminatedNCT00263874Phase 2
• Sodium Pyruvate Therapy in COPD PatientsCompletedNCT00262613Phase 2
• LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung CancerTerminatedNCT00260598Phase 2
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00259909
• Comparison Between Symbicort® and Prednisolone in COPDCompletedNCT00259779Phase 3
• Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)CompletedNCT00246935Phase 3
• Effects of Temazepam in Patients With Chronic Pulmonary Obstructive DiseaseCompletedNCT00245661Phase 3
• Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of LifeCompletedNCT00243282Not applicable
• Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)CompletedNCT00242320Phase 3
• Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)CompletedNCT00242294Phase 2/3
• 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDCompletedNCT00240435Phase 3
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
• 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDCompletedNCT00239473Phase 3
• Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239434Phase 3
• A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239421Phase 4
• Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).CompletedNCT00239408Phase 4
• Budesonide / Formoterol in Treatment of Exacerbations of COPDCompletedNCT00239278Phase 2
• Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health NetworksStatus unknownNCT00238836Phase 2/3
• The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary DiseaseTerminatedNCT00238082Not applicable
• Evaluating Genes in Sputum to Measure Drug Response in COPDTerminatedNCT00233051Not applicable
• Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
• Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ?TerminatedNCT00221819Not applicable
• Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD)Status unknownNCT00219648Phase 2
• A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00219622Phase 2
• Study in Patients With COPDCompletedNCT00215423Phase 2
• Exhale (R) Stent for EmphysemaCompletedNCT00207337Phase 2/3
• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPDCompletedNCT00206167Phase 3
• A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD PatientsCompletedNCT00206154Phase 3
• Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202189Phase 4
• Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202176Phase 4
• Primary Care Management/Action Plans for Advanced Chronic DiseasesCompletedNCT00202150Phase 2/3
• ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPDCompletedNCT00190437Phase 4
• How Smoking Causes COPD: Examination of Immune System ChangesStatus unknownNCT00186719
• Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00186706Phase 4
• COPD on Primary Care Treatment (COOPT)CompletedNCT00184977Phase 4
• Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00181272Phase 2
• Assessment of Ventilation-perfusion Abnormalities in Patients With Stable Smoking-related Airways DiseaseTerminatedNCT00180843Not applicable
• Regulation of the Release of Inflammatory Mediators From Blood LeukocytesWithdrawnNCT00180765
• NO Donors and Inhibitors to Study Imbalance of Nitrogen Stress and Antioxidant Defense in COPDCompletedNCT00180635Not applicable
• Markers for Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00180622
• Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
• Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00170222Phase 4
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseCompletedNCT00164138Not applicable
• A Study of UK-369,003 on the Safety and Efficacy in Patients With COPDCompletedNCT00163098Phase 1/2
• A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00162864Phase 3
• Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00159549Not applicable
• The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps MuscleCompletedNCT00159367Not applicable
• ATP/AMP Challenge in Healthy Non-smokers, Smokers, Patients With Asthma, and Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00159315Not applicable
• Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00159289Not applicable
• GR Defect in Sputum Cells in COPDWithdrawnNCT00159276
• GR Defect in Peripheral Blood Mononuclear Cells in COPDWithdrawnNCT00159237
• Modification Of Disease Outcome In COPDTerminatedNCT00158847Phase 4
• Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDCompletedNCT00157339Phase 3
• Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD PatientsCompletedNCT00157235Phase 3
• Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHFCompletedNCT00156780Phase 1
• Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00153075Phase 4
• Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of AsthmaCompletedNCT00152984Phase 4
• Regulation of Inflammatory Mediators in Chronic Obstructive Pulmonary DiseaseCompletedNCT00147095
• ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.CompletedNCT00144911Phase 4
• Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144859Phase 2
• A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
• 12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)CompletedNCT00144196Phase 4
• The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00141440Not applicable
• Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)CompletedNCT00139932Phase 4
• Chinese Community Smoking Cessation ProjectCompletedNCT00139516Not applicable
• Endobronchial Valve for Emphysema PalliatioN Trial (VENT) Cost-effectiveness Sub-StudyTerminatedNCT00137956Phase 3
• The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung DiseaseCompletedNCT00136006
• The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD PatientsStatus unknownNCT00135538Phase 3
• Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00134979Phase 4
• Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)Status unknownNCT00132860Phase 4
• Evaluation of Spirometry Expert Support in General PracticeStatus unknownNCT00131157Not applicable
• Study to Assess the Safety and Tolerability of Incremental Doses of QAB149 in Adults With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00129831Phase 2
• Endobronchial Valve for Emphysema Palliation Trial (VENT)CompletedNCT00129584Phase 3
• Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General PracticeCompletedNCT00128765Not applicable
• High Dose Trial in COPDCompletedNCT00128440Phase 2
• Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00122694Phase 2
• Dose Finding Study in COPDCompletedNCT00122434Phase 2
• Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled TrialStatus unknownNCT00120978Phase 4

← Pulmonary Disease, Chronic Obstructive overview